ArticleJournal of fluorescence2026
An Advanced Fluorescent Molecularly Imprinted Sensor Based on Carbon Quantum Dots for Highly Sensitive Detection of 6-Mercaptopurine.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study developed a fluorescent molecularly imprinted sensor (CDs@MIPs) for the highly selective detection of the anticancer drug 6-mercaptopurine (6-MP). 6-MP is an anti-cancer drug with myelosuppressive and hepatotoxic effects. If used improperly, it can cause serious adverse reactions in humans and other organisms. The sensor was fabricated via the sol-gel method using blue-emissive nitrogen-doped carbon dots (CDs) as the fluorophore and 3-aminopropyl triethoxysilane (APTES) as the functional monomer. The sensor leveraged molecularly imprinted technology to construct specific recognition cavities, which enabled highly efficient and sensitive detection of 6-MP. Under the optimal experimental conditions and at 325 nm excitation, with the increase of 6-MP concentration, the fluorescence intensity of the sensor at the emission of 415 nm gradually decreases. The sensor demonstrated a linear detection range of 5.0-120.0 µM (Y = - 6.55X + 792.39) with a detection limit of 1.67 µM (S/N = 3). It exhibited strong anti-interference capability, excellent reproducibility and stable fluorescence performance. When applied to the detection of Mercaptopurine tablets, the method achieved recovery rate of 97.80%-108.63%, providing a highly sensitive and cost-effective analytical approach for clinical drug monitoring.
Indexed as
Identifiers
41331188What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.